Position in LH
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$4,253,200
+$294,007 QoQ
Shares Held
15,190
+2.4% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#260
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026XPONANCE LLC holds $128,426,636 across 24 Diagnostics & Research names. LH ranks #11 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
68,808 | $34,497,578 | |
| 2 | DHR |
Danaher Corp /De/
|
117,140 | $22,312,827 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
25,318 | $13,328,407 | |
| 4 | NTRA |
Natera, Inc.
|
30,319 | $8,230,092 | |
| 5 | A |
Agilent Technologies, Inc.
|
51,163 | $6,795,981 | |
| 6 | WAT |
Waters Corp /De/
|
17,299 | $6,487,816 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
4,959 | $6,335,172 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
28,688 | $5,543,095 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,253,200 | 15,190 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $3,959,193 | 14,839 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,571,527 | 14,236 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,513,901 | 12,241 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,306,050 | 12,594 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,838,264 | 12,195 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $2,751,840 | 12,000 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,582,311 | 11,555 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,473,257 | 12,153 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||